The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
A variable-length poly-T variant in intron 6 of the TOMM40 gene, rs10524523, is associated with risk and age-of-onset of sporadic (late-onset) Alzheimer's disease. In Caucasians, the three predominant alleles at this locus are Short (S), Long (L) or Very long (VL). On an APOE ε3/3 background, the S/VL and VL/VL genotypes are more protective than S/S. The '523 poly-T has regulatory properties, in that the VL poly-T results in higher expression than the S poly-T in luciferase expression systems. The aim of the current work was to identify effects on cellular bioenergetics of increased TOM40 protein expression. MitoTracker Green fluorescence and autophagic vesicle staining was the same in control and over-expressing cells, but TOM40 over-expression was associated with increased expression of TOM20, a preprotein receptor of the TOM complex, the mitochondrial chaperone HSPA9, and PDHE1a, and increased activities of the oxidative phosphorylation complexes I and IV and of the TCA member α-ketoglutaric acid dehydrogenase. Consistent with the complex I findings, respiration was more sensitive to inhibition by rotenone in control cells than in the TOM40 over-expressing cells. In the absence of inhibitors, total cellular ATP, the mitochondrial membrane potential, and respiration were elevated in the over-expressing cells. Spare respiratory capacity was greater in the TOM40 over-expressing cells than in the controls. TOM40 over-expression blocked Ab-elicited decreases in the mitochondrial membrane potential, cellular ATP levels, and cellular viability in the control cells. These data suggest elevated expression of TOM40 may be protective of mitochondrial function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Production of Reactive Oxygen Species by Mitochondria
Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304854200 · Cited by 1,616
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., & Brinton, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903563106 · Cited by 940
Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-06.2006 · Cited by 792
The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786
Hansson Petersen, C. A., Alikhani, N., Behbahani, H., Wiehager, B., Pavlov, P. F., Alafuzoff, I., Leinonen, V., Ito, A., Winblad, B., Glaser, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806192105 · Cited by 693
Kapogiannis, D., & Mattson, M. P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70277-5 · Cited by 594
Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585
Coskun, P. E., Beal, M. F., & Wallace, D. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403649101 · Cited by 556
Defining the transcriptome and proteome in three functionally different human cell lines
Lundberg, E., Fagerberg, L., Klevebring, D., Matic, I., Geiger, T., Cox, J., Älgenäs, C., Lundeberg, J., Mann, M., & Uhlen, M. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.106 · Cited by 373
Chang, S., Ma, T. R., Miranda, R. D., Balestra, M. E., Mahley, R. W., & Huang, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508254102 · Cited by 319
Amyloid‐Beta Interaction with Mitochondria
Pagani, L., & Eckert, A. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/925050 · Cited by 309
Nicastrin, Presenilin, APH-1, and PEN-2 Form Active γ-Secretase Complexes in Mitochondria
Hansson, C. A., Frykman, S., Farmery, M. R., Tjernberg, L. O., Nilsberth, C., Pursglove, S. E., Ito, A., Winblad, B., Cowburn, R. F., Thyberg, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404500200 · Cited by 256
Villani, G., Greco, M., Papa, S., & Attardi, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31829 · Cited by 225
Chen, H.-K., Ji, Z.-S., Dodson, S. E., Miranda, R. D., Rosenblum, C. I., Reynolds, I. J., Freedman, S. B., Weisgraber, K. H., Huang, Y., & Mahley, R. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151084 · Cited by 209
Extramitochondrial localization of mortalin/mthsp70/PBP74/GRP75
Ran, Q., Wadhwa, R., Kawai, R., Kaul, S. C., Sifers, R. N., Bick, R. J., Smith, J. R., & Pereira-Smith, O. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3237 · Cited by 182
The role of mitochondria in inherited neurodegenerative diseases
Kwong, J. Q., Beal, M. F., & Manfredi, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03990.x · Cited by 180
Direct Transcriptional Effects of Apolipoprotein E
Theendakara, V., Peters-Libeu, C. A., Spilman, P., Poksay, K. S., Bredesen, D. E., & Rao, R. V. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3562-15.2016 · Cited by 152
Valla, J., Yaari, R., Wolf, A. B., Kusne, Y., Beach, T. G., Roher, A. E., Corneveaux, J. J., Huentelman, M. J., Caselli, R. J., & Reiman, E. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100129 · Cited by 150
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Roy, N., Hutfles, L., Burns, J. M., Michaelis, E. K., Yan, S., Cardoso, S. M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt247 · Cited by 133
Nakamura, T., Watanabe, A., Fujino, T., Hosono, T., & Michikawa, M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-35 · Cited by 124
An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease
Roses, A. D. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.88 · Cited by 118
Self-citationMitochondrial function impairment induced by amyloid β-peptide on PC12 cells
Pereira, C., Santos, M. S., & Oliveira, C. (1998) · NeuroReport · doi:10.1097/00001756-199806010-00015 · Cited by 115
Johnson, S. C., La Rue, A., Hermann, B. P., Xu, G., Koscik, R. L., Jonaitis, E. M., Bendlin, B. B., Hogan, K. J., Roses, A. D., Saunders, A. M., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.11.012 · Cited by 112
Self-citationUsing genetics to enable studies on the prevention of Alzheimer's disease
Crenshaw, D. G., Gottschalk, W. K., Lutz, M. W., Grossman, I., Saunders, A. M., Burke, J. R., Welsh-Bohmer, K. A., Brannan, S. K., Burns, D. K., & Roses, A. D. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.222 · Cited by 70
Longitudinal modeling of cognitive aging and the TOMM40 effect
Caselli, R. J., Dueck, A. C., Huentelman, M. J., Lutz, M. W., Saunders, A. M., Reiman, E. M., & Roses, A. D. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.11.006 · Cited by 69
Cloning and some novel characteristics of mitochondrial Hsp70 from Chinese hamster cells
Singh, B., Soltys, B. J., Wu, Z.-C., Patel, H. V., Freeman, K. B., & Gupta, R. S. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3609 · Cited by 51
A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease
Lutz, M. W., Sundseth, S. S., Burns, D. K., Saunders, A. M., Hayden, K. M., Burke, J. R., Welsh‐Bohmer, K. A., Roses, A. D., & Initiative, A. D. N. (2016) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2015.12.002 · Cited by 30
Self-citation
Research works printed but not linked: 80
- Swerdlow, 2012, Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease, Antioxid. Redox Signal., 16, 1434, 10.1089/ars.2011.4149 · DOI · Paper page
- Perkins, 2016, Altered energy metabolism pathways in the posterior cingulate in young adult apolipoprotein E varepsilon4 carriers, J. Alzheimers. Dis., 53, 95, 10.3233/JAD-151205 · DOI · Paper page
- Du, 2010, Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model, Proc. Natl. Acad. Sci., 107, 18670, 10.1073/pnas.1006586107 · DOI · Paper page
- Manczak, 2004, Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease, NeuroMolecular Med., 5, 147, 10.1385/NMM:5:2:147 · DOI · Paper page
- Hayden, 2010, Occupational exposure to pesticides increases the risk of incident AD: the Cache County study, Neurology, 74, 1524, 10.1212/WNL.0b013e3181dd4423 · DOI · Paper page
- Richardson, 2014, Elevated serum pesticide levels and risk for Alzheimer disease, JAMA Neurol., 71, 284, 10.1001/jamaneurol.2013.6030 · DOI · Paper page
- Moreno, 1991, Mitochondrial bioenergetics as affected by DDT, Biochim. Biophys. Acta Bioenerg., 1060, 166, 10.1016/S0005-2728(09)91004-0 · DOI
- Casley, 2002, β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities, J. Neurochem., 80, 91, 10.1046/j.0022-3042.2001.00681.x · DOI · Paper page
- Casley, 2002, β-Amyloid fragment 25–35 causes mitochondrial dysfunction in primary cortical neurons, Neurobiol. Dis., 10, 258, 10.1006/nbdi.2002.0516 · DOI · Paper page
- Chacinska, 2009, Importing mitochondrial proteins: machineries and mechanisms, Cell, 138, 628, 10.1016/j.cell.2009.08.005 · DOI · Paper page
- Anandatheerthavarada, 2007, Mitochondrial translocation of amyloid precursor protein and its cleaved products: relevance to mitochondrial dysfunction in Alzheimer's disease, Rev. Neurosci., 18, 343, 10.1515/revneuro.2007.18.5.343 · DOI · Paper page
- Cenini, 2016, Amyloid β-peptides interfere with mitochondrial preprotein import competence by a coaggregation process, Mol. Biol. Cell, 27, 3257, 10.1091/mbc.E16-05-0313 · DOI · Paper page
- Schaefer, 2016, Metabolic characterization of intact cells reveals intracellular amyloid Beta but not its precursor protein to reduce mitochondrial respiration, PLoS One, 11, 10.1371/journal.pone.0168157 · DOI · Paper page
- Saunders, 1993, Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, 1467, 10.1212/WNL.43.8.1467 · DOI · Paper page
- Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 10.1126/science.8346443 · DOI · Paper page
- Roses, 2010, A TOMM40 variable length polymorphism predicts the age of late-onset Alzheimer's disease, Pharmacogenomics J., 10, 375, 10.1038/tpj.2009.69 · DOI · Paper page
- Lutz, 2010, Genetic variation as a single locus and age of onset for Alzheimer's disease, Alzheimers Dement., 6, 125, 10.1016/j.jalz.2010.01.011 · DOI · Paper page
- Caselli, 2010, TOMM40, APOE and age of onset of Alzheimer's disease, Alzheimers Dement., 6, S202, 10.1016/j.jalz.2010.05.644 · DOI
- Hayden, 2012, A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging, Alzheimers Dement., 8, 381, 10.1016/j.jalz.2011.10.005 · DOI · Paper page
- Greenbaum, 2014, The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes, Eur. Neuropsychopharmacol., 24, 1492, 10.1016/j.euroneuro.2014.06.002 · DOI
- Laczó, 2015, The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment, Neurobiol. Aging, 36, 2024, 10.1016/j.neurobiolaging.2015.03.004 · DOI
- Payton, 2016, A TOMM40 poly-T variant modulates gene expression and is associated with vocabulary ability and decline in nonpathologic aging, Neurobiol. Aging, 39, 217.e211, 10.1016/j.neurobiolaging.2015.11.017 · DOI
- Linnertz, 2014, The cis‑regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes, Alzheimers Dement., 10, 541, 10.1016/j.jalz.2013.08.280 · DOI · Paper page
- Bekris, 2012, Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE, J. Hum. Genet., 57, 18, 10.1038/jhg.2011.123 · DOI · Paper page
- Hedskog, 2012, Biochemical studies of poly-T variants in the Alzheimer's disease associated TOMM40 gene, J. Alzheimers Dis., 31, 527, 10.3233/JAD-2012-120580 · DOI
- Baker, 1990, A yeast mitochondrial outer membrane protein essential for protein import and cell viability, Nature, 348, 605, 10.1038/348605a0 · DOI · Paper page
- Taylor, 2003, Characterization of Neurospora crassa Tom40-deficient mutants and effect of specific mutations on Tom40 assembly, J. Biol. Chem., 278, 765, 10.1074/jbc.M208083200 · DOI
- Rossignol, 2004, Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells, Cancer Res., 64, 985, 10.1158/0008-5472.CAN-03-1101 · DOI · Paper page
- Smith, 1988, Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements, J. Biol. Chem., 263, 8300, 10.1016/S0021-9258(18)68477-7 · DOI · Paper page
- Linnertz, 2014, The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes, Alzheimers Dement., 10, 541, 10.1016/j.jalz.2013.08.280 · DOI · Paper page
- Taylor, 2013, A defined methodology for reliable quantification of Western blot data, Mol. Biotechnol., 55, 217, 10.1007/s12033-013-9672-6 · DOI · Paper page
- Taylor, 2014, The design of a quantitative western blot experiment, Biomed. Res. Int., 2014, 8, 10.1155/2014/361590 · DOI · Paper page
- Zinchuk, 2007, Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena, Acta Histochem. Cytochem., 40, 101, 10.1267/ahc.07002 · DOI · Paper page
- Hynes, 2006, The use of a fluorescence-based oxygen uptake assay in the analysis of cytotoxicity, Toxicol. in Vitro, 20, 785, 10.1016/j.tiv.2005.11.002 · DOI
- Lo, 1996, Calibration of oxygen-dependent quenching of the phosphorescence of Pd-meso-tetra (4-carboxyphenyl) porphine: a phosphor with general application for measuring oxygen concentration in biological systems, Anal. Biochem., 236, 153, 10.1006/abio.1996.0144 · DOI · Paper page
- Hynes, 2006, Investigation of drug-induced mitochondrial toxicity using fluorescence-based oxygen-sensitive probes, Toxicol. Sci., 92, 186, 10.1093/toxsci/kfj208 · DOI · Paper page
- Rasmussen, 2003, Oxygen solubilities of media used in electrochemical respiration measurements, Anal. Biochem., 319, 105, 10.1016/S0003-2697(03)00274-4 · doi:10.1016/s0003-2697(03)00274-4
- Das, 1997, Preferential interaction of a novel tumor surface protein (p38.5) with naive natural killer cells, J. Exp. Med., 185, 1735, 10.1084/jem.185.10.1735 · DOI
- Coleman, 2010, A live-cell fluorescence microplate assay suitable for monitoring vacuolation arising from drug or toxic agent treatment, J. Biomol. Screen., 15, 398, 10.1177/1087057110364242 · DOI
- Kim, 2014, Abstract 2456: overexpression of TOM40 (translocase in the outer mitochondrial membrane 40) inhibits the cell proliferation, invasion and migration abilities in ovarian cancer cell lines, Cancer Res., 74, 2456, 10.1158/1538-7445.AM2014-2456 · doi:10.1158/1538-7445.am2014-2456
- Steinlechner-Maran, 1996, Oxygen dependence of respiration in coupled and uncoupled endothelial cells, Am. J. Phys., 271, C2053
- Brand, 2011, Assessing mitochondrial dysfunction in cells, Biochem. J., 435, 297, 10.1042/BJ20110162 · DOI · Paper page
- Wu, 1959, Regulatory mechanisms in carbohydrate metabolism. V. Limiting factors of glycolysis in HeLa cells, J. Biol. Chem., 234, 2806, 10.1016/S0021-9258(18)69674-7 · DOI · Paper page
- Murphy, 2009, How mitochondria produce reactive oxygen species, Biochem. J., 417, 1, 10.1042/BJ20081386 · DOI · Paper page
- Fato, 2009, Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species, Biochim. Biophys. Acta Bioenerg., 1787, 384, 10.1016/j.bbabio.2008.11.003 · DOI · Paper page
- Caspersen, 2005, Mitochondrial A{beta}: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease, FASEB J., 19, 2040, 10.1096/fj.05-3735fje · DOI · Paper page
- Muirhead, 2010, The consequences of mitochondrial amyloid b-peptide in Alzheimer's disease, Biochem. J., 426, 255, 10.1042/BJ20091941 · DOI
- Chen, 2015, Amyloid-β peptide-induced cytotoxicity and mitochondrial dysfunction in yeast, FEMS Yeast Res., 15, 10.1093/femsyr/fov061 · DOI
- Chen, 2010, Role of mitochondrial amyloid-β in Alzheimer's disease, J. Alzheimers Dis., 20, 569, 10.3233/JAD-2010-100357 · DOI · Paper page
- Keil, 2006, Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations, J. Alzheimers Dis., 9, 139, 10.3233/JAD-2006-9206 · DOI · Paper page
- Bobba, 2013, Mitochondrial respiratory chain Complexes I and IV are impaired by β-amyloid via direct interaction and through Complex I-dependent ROS production, respectively, Mitochondrion, 13, 298, 10.1016/j.mito.2013.03.008 · DOI
- Takuma, 2005, ABAD enhances Aβ-induced cell stress via mitochondrial dysfunction, FASEB J., 19, 597, 10.1096/fj.04-2582fje · DOI · Paper page
- Yoon, 2009, Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis, Exp. Mol. Med., 41, 611, 10.3858/emm.2009.41.9.067 · DOI
- Walls, 2012, Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and beta-amyloid, J. Biol. Chem., 287, 30317, 10.1074/jbc.M112.365890 · DOI · Paper page
- Mossmann, 2014, Amyloid-β peptide induces mitochondrial dysfunction by inhibition of preprotein maturation, Cell Metab., 20, 662, 10.1016/j.cmet.2014.07.024 · DOI · Paper page
- Yu, 2017, TOMM40'523 variant and cognitive decline in older persons with APOE ε3/3 genotype, Neurology, 88, 661, 10.1212/WNL.0000000000003614 · DOI · Paper page
- Rapaport, 2001, Structural requirements of Tom40 for assembly into preexisting TOM complexes of mitochondria, Mol. Biol. Cell, 12, 1189, 10.1091/mbc.12.5.1189 · DOI
- Sherman, 2006, Effect of mutations in Tom40 on stability of the translocase of the outer mitochondrial membrane (TOM) complex, assembly of Tom40, and import of mitochondrial preproteins, J. Biol. Chem., 281, 22554, 10.1074/jbc.M601630200 · DOI
- Gabriel, 2003, Tom40, the import channel of the mitochondrial outer membrane, plays an active role in sorting imported proteins, EMBO J., 22, 2380, 10.1093/emboj/cdg229 · DOI
- Suzuki, 2004, Membrane-embedded C-terminal segment of rat mitochondrial TOM40 constitutes protein-conducting pore with enriched β-structure, J. Biol. Chem., 279, 50619, 10.1074/jbc.M408604200 · DOI
- Kuszak, 2015, Evidence of distinct channel conformations and substrate binding affinities for the mitochondrial outer membrane protein translocase pore Tom40, J. Biol. Chem., 290, 26204, 10.1074/jbc.M115.642173 · DOI
- van Waveren, 2008, Transcriptional co-expression and co-regulation of genes coding for components of the oxidative phosphorylation system, BMC Genomics, 9, 1, 10.1186/1471-2164-9-18 · DOI
- Humphries, 2005, Dissection of the mitochondrial import and assembly pathway for human Tom40, J. Biol. Chem., 280, 11535, 10.1074/jbc.M413816200 · DOI · Paper page
- Wiedemann, 2003, Machinery for protein sorting and assembly in the mitochondrial outer membrane, Nature, 424, 565, 10.1038/nature01753 · DOI · Paper page
- Shiota, 2012, The Tom40 assembly process probed using the attachment of different intramitochondrial sorting signals, Mol. Biol. Cell, 23, 3936, 10.1091/mbc.e12-03-0202 · DOI
- Voos, 2016, Protein quality control at the mitochondrion, Essays Biochem., 60, 213, 10.1042/EBC20160009 · DOI
- Sacht, 1999, ATP-sensitive association of mortalin with the IL-1 receptor type I, Biofactors, 9, 49, 10.1002/biof.5520090107 · DOI
- Poindexter, 2002, 3D reconstruction and localization of mortalin by deconvolution microscopy, Microsc. Anal., 21
- Kaul, 2005, Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides, J. Biol. Chem., 280, 39373, 10.1074/jbc.M500022200 · DOI
- Bender, 2011, Mitochondrial enzymes are protected from stress-induced aggregation by mitochondrial chaperones and the Pim1/LON protease, Mol. Biol. Cell, 22, 541, 10.1091/mbc.e10-08-0718 · DOI
- Kiss, 2013, The negative impact of α-ketoglutarate dehydrogenase complex deficiency on matrix substrate-level phosphorylation, FASEB J., 27, 2392, 10.1096/fj.12-220202 · DOI · Paper page
- Chinopoulos, 2013, Which way does the citric acid cycle turn during hypoxia? The critical role of α-ketoglutarate dehydrogenase complex, J. Neurosci. Res., 91, 1030, 10.1002/jnr.23196 · DOI · Paper page
- Berndt, 2012, Kinetic modeling of the mitochondrial energy metabolism of neuronal cells: the impact of reduced α-ketoglutarate dehydrogenase activities on ATP production and generation of reactive oxygen species, Int. J. Cell Biol., 2012, 11, 10.1155/2012/757594 · DOI
- Groen, 1982, Quantification of the contribution of various steps to the control of mitochondrial respiration, J. Biol. Chem., 257, 2754, 10.1016/S0021-9258(19)81026-8 · DOI · Paper page
- Ventura, 2002, Control of oxidative phosphorylation by Complex I in rat liver mitochondria: implications for aging, Biochim. Biophys. Acta Bioenerg., 1553, 249, 10.1016/S0005-2728(01)00246-8 · DOI
- Telford, 2009, Complex I is rate-limiting for oxygen consumption in the nerve terminal, J. Biol. Chem., 284, 9109, 10.1074/jbc.M809101200 · DOI
- Lee, 2012, Downregulation of TOMM40 expression in the blood of Alzheimer disease subjects compared with matched controls, J. Psychiatr. Res., 46, 828, 10.1016/j.jpsychires.2012.03.006 · DOI
- Chong, 2013, Gene expression profiling of peripheral blood leukocytes shows consistent longitudinal downregulation of TOMM40 and upregulation of KIR2DL5A, PLOD1, and SLC2A8 among fast progressors in early Alzheimer's disease, J. Alzheimers Dis., 34, 399, 10.3233/JAD-121621 · DOI · Paper page
- Goh, 2015, TOMM40 alterations in Alzheimer's disease over a 2-year follow-up period, J. Alzheimers Dis., 44, 57, 10.3233/JAD-141590 · DOI
- Bender, 2013, TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease, PLoS One, 8, 10.1371/journal.pone.0062277 · DOI · Paper page
Cited by
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
Belloy, M. E., Napolioni, V., & Greicius, M. D. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.056 · Cited by 570
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Mahley, R. W. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102684 · Cited by 43
Ramos de Matos, M., Ferreira, C., Herukka, S.-K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. R., Lleó, A., Dols-Icardo, O., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180512 · Cited by 18
Osteosarcoma neutrophil extracellular trap network-associated gene recurrence and metastasis model
Tang, H., Xie, J., Du, Y.-X., Tan, Z.-J., & Liang, Z.-T. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05577-2 · Cited by 14
“Several studies have reported that translocase of the mitochondrial outer membrane 40 (TOMM40) gene may increase the risk of developing Alzheimer's disease (AD) (Lee et al. 2021; Zeitlow et al. 2017).”
Metadata
- Authors
- Zeitlow, K., Charlambous, L., Ng, I., Gagrani, S., Mihovilovic, M., Luo, S., Rock, D. L., Saunders, A., Roses, A. D., & Gottschalk, W. K.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 1863
- Issue
- 11
- Pages
- 2973-2986
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2739591311
- Cited by
- 54
- References
- 33
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Update notices
- erratum (2018-04-01)
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Institutes of Aging (R01 AG040370)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.